clear
Wednesday October 18th, 2017 1:47AM

Science Says: Not all cancers need treatment right away

By The Associated Press
Related Articles
  Contact Editor

The biopsy shows cancer, so you have to act fast, right? Not necessarily, if it's a prostate tumor.

Men increasingly have choices if their cancer is found at an early stage, as most cases in the U.S. are. They can treat it right away or monitor with periodic tests and treat later if it worsens or causes symptoms.

Now, long-term results are in from one of the few studies comparing these options in men with tumors confined to the prostate. After 20 years, death rates were roughly similar for those who had immediate surgery and those initially assigned to monitoring, and surgery had more side effects.

"Many men, when they hear the word cancer, you want to do something about it," said one study leader, Dr. Gerald Andriole, urology chief at Washington University in St. Louis, Missouri. "The reality is, if you have a low-risk cancer, like the study shows, you don't need treatment, certainly not urgently."

It's not all black and white, though. Early stage doesn't necessarily mean low risk. Some results in the study lean in favor of surgery, and it does have some advantages. It also may improve survival for certain groups. Here's what this and other studies tell us about who does and doesn't benefit from surgery.

WHY NOT TREAT EVERYONE?

Start with a fact many find hard to accept: Not all cancers are destined to kill. Some prostate tumors are deadly, but most grow so slowly that men will die of something else.

Treatments — surgery, radiation or hormone therapy — can cause impotence, incontinence, infections and other problems, and sometimes do more harm than the disease ever would.

Monitoring doesn't mean do nothing. Men can get frequent tests, and there are more and better ways to detect disease progression now than there used to be, so there's usually still a chance to treat and potentially cure it if it starts to worsen, Andriole said.

WHAT THE EVIDENCE SAYS

Only a few studies have tested monitoring versus immediate treatment. One found no difference in death rates after more than 20 years; another found surgery improved survival odds, but only for men under 65.

Those were done before wide use of PSA blood tests, back when more tumors were found because they caused symptoms, which often means more advanced disease.

Researchers wondered: Would the results be the same with modern screening and treatments?

The new study, sponsored by the U.S. Department of Veterans Affairs, aimed to answer that. Doctors assigned 731 men to observation or surgery. After a decade, survival rates were similar, but doctors wanted longer follow-up.

Now, after 20 years, two thirds of these men have died and the original conclusions still stand, though the numbers leaned in surgery's favor. Fewer men died in the surgery group, but the difference was small enough that it could have been due to chance. Only about 9 percent of men ultimately died from prostate cancer, showing how relatively seldom the disease proves fatal.

Results are in Thursday's New England Journal of Medicine.

DID SURGERY DO ANY GOOD?

Yes. Fewer men in the surgery group later had treatment because there were signs the disease might be worsening — 34 percent, versus 60 percent of the group assigned to monitoring. In many cases, it was prompted by rising PSA levels, but surgery also clearly prevented more cases from spreading throughout the body.

Half of the group assigned to monitoring wound up getting some sort of treatment within five years. In one quarter of those cases, men "just got fed up" with monitoring and thinking about cancer, Andriole said. The rest were prompted by signs of progression.

Surgery also may have improved survival for men in the middle range of risk, with PSA levels between 10 and 20, and a Gleason score (a measure of how aggressive cancer cells look under a microscope) of 7. Only about one quarter to one third of men in the U.S. fall in this category, though. Most men are early stage and low risk.

"Surgery is right for the right person, and it's somebody with intermediate-risk disease," Andriole said.

SIDE EFFECTS

Surgery had more side effects — 15 percent of men in that group later sought treatment for trouble having sex, and 17 percent, for incontinence. The numbers were 5 percent and 4 percent, respectively, of men assigned to observation.

"You can't divorce quality of life outcomes from cancer outcomes because they both count for patients," said Dr. David Penson, Vanderbilt University's urology chief, who had no role in the study.

"Some guys will look at this and say, 'I don't want to be impotent, I don't want to be incontinent,'" and will forgo surgery even if there's a chance it will help them live longer, he said. "In the end, each man's going to make his own decision."

___

Marilynn Marchione can be followed on Twitter: @MMarchioneAP

___

This Associated Press series was produced in partnership with the Howard Hughes Medical Institute's Department of Science Education. The AP is solely responsible for all content.

  • Associated Categories: U.S. News, Associated Press (AP), AP National News, Top U.S. News short headlines, AP Health, AP Health - Men's Health
© Copyright 2017 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
Trump in Paris: The curious case of his friend Jim
When President Donald Trump takes his first official trip to Paris Thursday, it's unlikely that his enigmatic friend Jim will tag along
5:04PM ( 4 minutes ago )
Science Says: Not all cancers need treatment right away
Surgery didn't help men with early-stage prostate cancer live longer compared to monitoring their disease, long-term results suggest
5:03PM ( 4 minutes ago )
Where's Rey? Despite Monopoly maker's promise, still missing
The Rey character from the "Star Wars" version of Monopoly apparently is in a land far, far away
4:57PM ( 10 minutes ago )
U.S. News
Brittany Lang needs better to defend in US Women's Open
The U.S. Women's Open has not had a repeat winner since Karrie Webb in 2001 and the chances of Brittany Lang doing it this year don't seem good
4:57PM ( 11 minutes ago )
FDA advisers endorse what could be 1st US gene therapy
FDA advisers hear details about what could be the first gene therapy approved in the U.S.
4:53PM ( 14 minutes ago )
French court annuls Google's $1.27 billion back tax bill
A French court annulled Wednesday a 1.1 billion-euro ($1.27 billion) tax adjustment imposed on Google by France's tax authorities, saying the way the California firm operates in the country allows it to be exempt from most taxes
4:50PM ( 17 minutes ago )
Associated Press (AP)
Trump says he'll be 'angry' if Senate health care bill flops
President Donald Trump says he will be "very angry" if the Senate fails to pass a revamped Republican health care bill
4:22PM ( 45 minutes ago )
Latino plaintiffs sue California alleging poor health care
A court challenge says California is harming medical care for more than 13 million lower-income residents _ the majority of them Latinos _ by failing to pay doctors enough to provide proper care
3:22PM ( 1 hour ago )
NYC launches $32 million plan to reduce rat population
New York City announces a $32 million, multi-agency plan to reduce its rat population
3:04PM ( 2 hours ago )
AP Health
Rockies' Bettis back with team following cancer treatment
Chad Bettis has rejoined the Colorado Rockies and begun throwing after finishing treatment for testicular cancer
8:46PM ( 1 month ago )
Pirates pitcher Jameson Taillon upbeat in cancer fight
Pittsburgh Pirates pitcher Jameson Taillon says he's received nothing but positive news since being diagnosed with testicular cancer earlier this month
7:47PM ( 1 month ago )
McConnell asks all senators to join all-male health group
Senate Majority Leader Mitch McConnell has invited all Republicans to join with what's been an all-male working group of GOP senators to craft a health care bill
6:36PM ( 2 months ago )
AP Health - Men's Health
Trump in Paris: The curious case of his friend Jim
When President Donald Trump takes his first official trip to Paris Thursday, it's unlikely that his enigmatic friend Jim will tag along
5:04PM ( 4 minutes ago )
Where's Rey? Despite Monopoly maker's promise, still missing
The Rey character from the "Star Wars" version of Monopoly apparently is in a land far, far away
4:57PM ( 10 minutes ago )
DA: Man held on $5M cash bail amid search for 4 missing men
A 20-year-old linked to a Pennsylvania farm at the center of a search for four missing men was arrested on charges he tried to sell one man's car after he went missing, authorities said in announcing the first big break in the case
4:50PM ( 17 minutes ago )
Yellen says Fed watching slowdown in inflation
Yellen to Congress: Recent inflation slowdown could lead Fed to rethink pace of rate hikes
4:38PM ( 29 minutes ago )
No monkeying around: Court weighs if animal owns its selfies
A federal appeals court has heard arguments on whether a curious monkey with a knack for pressing a camera button can hold a copyright
4:24PM ( 44 minutes ago )